Minnow Street Minnow Street
Buy Day today: Poor Neutral (49) Good Mixed market breadth · no major macro event

Plexus Corp (PLXS)

Technology Electronic Components
252.60 $
Closing price · As of: 20. Jul 2026
🔔 Watch stock
Read the Full Deep Dive
Plexus Stock: Four Billion in Revenue — and Why Only a Twentieth of It Survives as Profit

Plexus builds complex electronics for other companies’ brands — ventilators, defense electronics, industrial gear — and shows up in our "Joshua" growth scanner while the stock has more than doubled in twelve months (data as of July 17, 2026). We read the annual reports (10-K) for fiscal years 2024 and 2025 and the quarterly report (10-Q) as of April 4, 2026: a good $4 billion in revenue, of which only about five cents on the dollar survives as operating profit — a record profit, a re-accelerating top line (plus 18.7 percent in the latest quarter), and the question of why the market pays 43 times earnings for a contract manufacturer. Not investment advice — just a reminder that a big revenue number is not the same as a big margin.

Appears in These Scanners

This stock currently matches 22 of our scanner strategies — each hit links to the scanner.

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners

Basics

Market Cap
7.9Mrd. $
Shares Outstanding
27Mio.
Float
98.5%
Beta
0.9

Performance

Perf. 1M
7.40%
Perf. 3M
44.50%
Perf. 6M
86.90%
YTD Performance (%)
96.30%
52-Week-High Distance
-3.3%

Valuation

P/E
43.5
Forward P/E
28.7
PEG
2.1
P/B
5.3
P/S
1.8
EV/EBITDA
24.7
Price/FCF
104.7

Profitability

Gross Margin
10.1%
EBIT Margin
5.3%
Net Margin
4.4%
Return on Equity
13.2%
Return on Assets
4.3%

Balance Sheet & Safety

Equity Ratio
44.3%
Debt/Equity
0.2
Altman Z
8.35
very solid
Piotroski
8 von 9

Growth

Sales Growth Last Quarter
18.70%
EPS Growth Last Quarter
29.10%
Sales Growth (Year)
1.82%
Forward Sales Growth
10.88%
Forward EPS Growth
15.10%

Quality & Screener

Stage
2
Top 10%
RS Rating
91
EPS Rating
70
very solid
Piotroski
8 von 9
Fundamental Rating
B (+31 von 100)
Altman Z
8.35

AI Rating

Uses AI

Plexus ist ein Auftragsfertiger für komplexe Elektronik (EMS) und verkauft keine KI-Produkte — KI ist keine Umsatzquelle. Die Geschäftsberichte (10-K FY 2025 und FY 2024, Item 1 „Business“) belegen aber ausdrücklich den operativen Einsatz von Künstlicher Intelligenz in der eigenen Fertigung: Plexus investiert in KI, Prozess- und Lagerautomatisierung sowie Echtzeit-Bildverarbeitung/Anomalieerkennung, um Produktivität und operative Effizienz zu steigern. Die KI-Nennungen im Risikoabschnitt (Wettbewerber könnten schneller auf KI reagieren; Technologien wie KI könnten Personal/Anlagen obsolet machen) sind generische Technologiewandel-Floskeln ohne konkreten, KI-spezifischen Modellbezug und begründen kein „bedroht“. Damit greift Rang 3: nutzt KI.

View the full file — quotes, sources, reviewed filings
„In addition to our core solutions, we are committed to investing in new platform technologies, such as advanced manufacturing execution systems, process automation, warehouse automation, artificial intelligence, real-time vision and anomaly detection systems and collaboration tools. These investments are aimed at enhancing productivity, optimizing operational efficiency, and driving differentiation in a competitive landscape."

Über unsere Kernlösungen hinaus sind wir entschlossen, in neue Plattform-Technologien zu investieren — etwa fortschrittliche Fertigungssteuerungssysteme, Prozessautomatisierung, Lagerautomatisierung, Künstliche Intelligenz, Echtzeit-Bildverarbeitung und Anomalieerkennungssysteme sowie Kollaborationswerkzeuge. Diese Investitionen zielen darauf ab, die Produktivität zu steigern, die operative Effizienz zu optimieren und die Differenzierung in einem Wettbewerbsumfeld voranzutreiben.

10-K · 2025-11-14 · View SEC filing
„In addition to our core solutions, we are committed to investing in new platform technologies, such as advanced manufacturing execution systems, process automation, warehouse automation, artificial intelligence, realtime vision and anomaly detection systems and collaboration tools. These investments are aimed at enhancing productivity, optimizing operational efficiency, and driving differentiation in a competitive landscape."

Über unsere Kernlösungen hinaus sind wir entschlossen, in neue Plattform-Technologien zu investieren — etwa fortschrittliche Fertigungssteuerungssysteme, Prozessautomatisierung, Lagerautomatisierung, Künstliche Intelligenz, Echtzeit-Bildverarbeitung und Anomalieerkennungssysteme sowie Kollaborationswerkzeuge. Diese Investitionen zielen darauf ab, die Produktivität zu steigern, die operative Effizienz zu optimieren und die Differenzierung in einem Wettbewerbsumfeld voranzutreiben.

10-K · 2024-11-15 · View SEC filing

Filings Reviewed: 10-Q 2026-05-07 · 10-Q 2026-02-05 · 10-Q 2025-08-01 · 10-Q 2025-05-02 · 10-K 2025-11-14 · 10-K 2024-11-15

Rated on July 17, 2026 · How the Rating Is Built

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Sales Per Quarter ($M)
2024: Q4 · 976.1 Mio. $ Q4 2025: Q1 · 980.2 Mio. $ Q1 2025: Q2 · 1,018.3 Mio. $ Q2 2025: Q3 · 1,058.4 Mio. $ Q3 2025: Q4 · 1,069.9 Mio. $ Q4 2026: Q1 · 1,163.8 Mio. $ Q1
Earnings Per Share Per Quarter ($)
2024: Q4 · 1.34 $ Q4 2025: Q1 · 1.41 $ Q1 2025: Q2 · 1.64 $ Q2 2025: Q3 · 1.87 $ Q3 2025: Q4 · 1.51 $ Q4 2026: Q1 · 1.82 $ Q1
Net Margin Per Quarter (%)
2024: Q4 · 3.8 % Q4 2025: Q1 · 4.0 % Q1 2025: Q2 · 4.4 % Q2 2025: Q3 · 4.9 % Q3 2025: Q4 · 3.8 % Q4 2026: Q1 · 4.3 % Q1
Operating Cash Flow Per Quarter ($M)
2024: Q4 · 53.6 Mio. $ Q4 2025: Q1 · 36.7 Mio. $ Q1 2025: Q2 · 26.9 Mio. $ Q2 2025: Q3 · 132.0 Mio. $ Q3 2025: Q4 · -15.4 Mio. $ Q4 2026: Q1 · 28.5 Mio. $ Q1
Free Cash Flow Per Quarter ($M)
2024: Q4 · 27.1 Mio. $ Q4 2025: Q1 · 16.5 Mio. $ Q1 2025: Q2 · 13.2 Mio. $ Q2 2025: Q3 · 97.2 Mio. $ Q3 2025: Q4 · -50.6 Mio. $ Q4 2026: Q1 · 16.0 Mio. $ Q1
Sales Growth vs. Year-Ago Quarter (%)
2024: Q4 · -0.7 % Q4 2025: Q1 · 1.4 % Q1 2025: Q2 · 6.0 % Q2 2025: Q3 · 0.7 % Q3 2025: Q4 · 9.6 % Q4 2026: Q1 · 18.7 % Q1
EPS Growth vs. Year-Ago Quarter (%)
2024: Q4 · 28.7 % Q4 2025: Q1 · 142.9 % Q1 2025: Q2 · 81.0 % Q2 2025: Q3 · 26.3 % Q3 2025: Q4 · 12.2 % Q4 2026: Q1 · 28.8 % Q1
Price Change in Quarter (%)
2024: Q4 · 14.5 % Q4 2025: Q1 · -18.1 % Q1 2025: Q2 · 5.6 % Q2 2025: Q3 · 6.9 % Q3 2025: Q4 · 1.6 % Q4 2026: Q1 · 37.8 % Q1

Quarterly Figures

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 1.34 28.70 976 -0.70 3.80 54 27
2025: Q1 1.41 142.90 980 1.40 4.00 37 17
2025: Q2 1.64 81.00 1,018 6.00 4.40 27 13
2025: Q3 1.87 26.30 1,058 0.70 4.90 132 97
2025: Q4 1.51 12.20 1,070 9.60 3.80 -15 -51
2026: Q1 1.82 28.80 1,164 18.70 4.30 29 16
What Do These Terms Mean?
EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Assessment: Opportunities & Risks

Growth & order book

Revenue in the second quarter of fiscal year 2026 (through April 4, 2026) up 18.7 percent to $1.16 billion, per the quarterly report on production ramps of new products for existing (+$87.2M) and new customers (+$28.9M); net income up 27.5 percent. Genuine, won order growth, not a mere market tailwind (10-Q as of 04/04/2026).

Profitability & margin

Record net income of $172.9 million in fiscal 2025 (+54.6 percent), operating margin improved to 5.0 percent (+80 bps) — but at its core a five-percent-margin business: of $4 billion in revenue, only about four cents on the dollar remain. Part of the earnings jump also came from interest expense falling from $28.9 million to $11.6 million (10-K FY 2025).

Concentration risks (customers & Malaysia)

The ten largest customers account for 49.1 percent of revenue, the business runs through individual "programs" with a limited life; at the same time the majority of revenue and operating income is earned abroad, "with a particular concentration in Malaysia" (10-K FY 2025, Item 1/1A). Two concentration risks a supposed U.S. stock hides at first glance.

Balance sheet & cash cushion

$303.1 million in cash against roughly $137.8 million of financial debt, $1.45 billion in equity on $3.14 billion in total assets (equity ratio around 46 percent), return on equity 13.2 percent — one of the more solid balance sheets in the industry and a buffer for cyclical troughs (10-Q as of 04/04/2026).

Valuation & technicals

A trailing P/E around 43 and P/S around 1.8 (data as of July 17, 2026) are historically expensive for a low-margin contract manufacturer — the price (up 114 percent in twelve months) already bakes in a durable margin improvement. Growth and trend hits (Joshua, Stan Weinstein stage 2) meet a sporty price tag.

Bottom Line

Plexus is a rock-solid, profitable company with a clean balance sheet, genuine order growth (plus 18.7 percent in the latest quarter) and a record profit. But it remains a contract manufacturer with a razor-thin margin: of $4 billion in revenue only about five cents of operating profit survive on the dollar, half the business hangs on ten customers, and the profit is earned mostly in Asia. At a trailing P/E around 43 the market is paying a growth price for a five-percent-margin business. Whoever invests here is betting the shift into higher-margin niches justifies the price tag. Not investment advice.

Worth Noting:
  • PLXS reached our research list via the "Joshua" growth scanner plus trend confluence in our in-house stock scanner (data as of July 17, 2026): Stan Weinstein stage 2, above the 50- and 200-day averages, RS leader ≥ 90, near 52-week high; analyst consensus 1.4 of 5.
  • All fiscal-year and quarterly references carry the 52/53-week offset: fiscal 2025 ended September 27, 2025, and the second quarter of fiscal 2026 ended April 4, 2026. Segment and concentration figures from the 10-K for fiscal 2025 (Item 1/1A, Note 11).
  • Price and valuation figures are dated to July 17, 2026 (price around $270, market value roughly $7.4 billion); analyses are evergreen, daily prices are not a buy argument. Interest expense fell from $31.5 million to $11.6 million in two years — part of the earnings increase is thus one-time relief.

About the Company

Plexus Corp. bietet elektronische Fertigungsdienste in den USA, dem asiatisch-pazifischen Raum, Europa, dem Nahen Osten und Afrika an.

CEO Insider Trades (12 Mo.)selling own stock
Employees20,000
HeadquartersNeenah, WI
Websiteplexus.com
IPO Date5. Feb 1986
Next Earnings22. Jul 2026

Management

Management
Name Title Birth Year
Todd P. Kelsey President, CEO & Director 1965
Oliver K. Mihm Executive VP & COO 1972
Angelo M. Ninivaggi J.D. Executive VP, Chief Legal & Public Affairs Officer and Secretary 1967
Victor Tan Regional President of APAC 1964
David Abuhl CFO & Senior VP
Kyle McMillan Chief Information & Technology Officer
Shawn Matthew Harrison Vice President of Investor Relations
Lori Ney Chief Human Resources Officer
Michael J. Running Regional President of AMER 1976
Scott Theune Chief Quality Officer 1965

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Chart

Interactive price chart (TradingView).

Data as of: July 20, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?